Changes in serum electrolytes during treatment of patients in liver failure with molecular adsorbent recirculating system
Doria, C.; Doyle, H.R.; Mandalà, L.; Marino, I.R.; Caruana, G.; Gruttadauria, S.; Lauro, A.; Magnone, M.; Scotti Foglieni, C.; Lamonaca, V.; Scott, V.L.
International Journal of Artificial Organs 26(10): 918-923
2003
ISSN/ISBN: 0391-3988 PMID: 14636008 Document Number: 557984
Purpose: To study the effect of MARS on serum electrolytes during liver failure. Design: Twenty-three patients admitted to a quaternary health care facility from September 2000 to May 2002, 22 adults and 1 child, 11 males (48%) and 12 females (52%), age 15-70 (median 53), treated with MARS for: 12 acute-on-chronic liver failure (52%); 4 fulminant hepatic failure (17%); 3 intractable pruritus (13%); 2 primary-non-function (9%); 2 following major liver resection (9%). Procedures: Sodium, potassium, chloride, phosphorus, calcium, and magnesium were measured in the serum, ultrafiltrate and albumin circuit before and after MARS. Statistical methods: A comparison of electrolyte concentrations, before and after MARS, was performed using a paired t test. Main findings: Serum electrolyte concentrations before and after MARS, while statistically significant in some cases, were very small, and of no clinical relevance. Conclusion: MARS exchanges potassium, chloride, calcium, and magnesium by ultrafiltration; sodium by the albumin dialysis.